Molecular and GI Pathologist, Brigham and Women's Hospital & Assistant Professor of Pathology, Harvard Medical School
BIOGRAPHY
MAR 13, 2024 8:00 AM PDT
Spatial Protein and RNA Profiling: Seeing the Unseen in the Tumor Microenvironment
Speaker
Event Date & Time
Date: March 13, 2024
Time: 8:00 AM (PST), 11:00 AM (EST), 4:00 PM (CET)
Abstract
Our presenter Jonathan Nowak, will discuss representative multiplexed assays for protein and RNA profiling built in the lab and discuss the necessary elements to operationalize this type of testing in a translational research laboratory. He will also explore the advantages of different assays and key considerations for ensuring consistently high data quality spanning hundreds to thousands of specimens.
Learning Objectives
-
Identify the benefits of digital, quantitative tumor microenvironment profiling over traditional qualitative approaches.
-
Explore the different types of protein and RNA spatial profiling approaches that are compatible with formalin-fixed paraffin-embedded tissue.
-
Review the laboratory and computational requirements for designing and analyzing multiplex immunofluorescence assays.
FOR RESEARCH USE ONLY. Not For Use In Diagnostic Procedures.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
DEC 12, 2023 15:00 CET
C.E. CREDITS
The implementation of the new CE-In Vitro Diagnostics Regulation (IVDR) involves challenges faced by labs that are working within the diagnostic environment. The aim of this event is to get...
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024 -
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
MAY 23, 2024For the Love of Digital PCR 2024
- See More
-
APR 27, 2024
- See More
